DrugBiological
Mitazalimab clinical trials
Also written ADC-1013 and JNJ-64457107.
- studies test it
- 5
- open now
- 2
- in phase 3
- 1
- first study started
- 2015
Keep track of what changes. Save the mitazalimab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
5 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 3
Joachim Aerts, MD PhD (1) · Janssen Research & Development, LLC (1) · Alligator Bioscience AB (1) · UNICANCER (1) · University of Pennsylvania (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses mitazalimab is read from its arms, and is right about nine times in ten.
Testing it · 5
- Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic CancerRecruitingPhase 2University of PennsylvaniaNCT07199764Written as Mitazalimab
- Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract CancersNot yet recruitingPhase 2/3UNICANCERNCT07437287Written as Mitazalimab
- MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)CompletedPhase 1Joachim Aerts, MD PhDNCT05650918Written as Mitazalimab
- A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage TumorsCompletedPhase 1Janssen Research & Development, LLCNCT02829099Written as JNJ-64457107
- ADC-1013 First-in-Human StudyCompletedPhase 1Alligator Bioscience ABNCT02379741Written as ADC-1013
Codes
What other systems call mitazalimab · ClinicalTrials.gg INT000346
- MeSH (NLM) C000602878mitazalimabConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Q9J81E7VFMMITAZALIMABConfirmed FDA, NLM
- NCI Thesaurus C121538MitazalimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000602878 | mitazalimab | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Q9J81E7VFM | MITAZALIMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C121538 | Mitazalimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.